A COMPARATIVE ANALYSIS OF CLINICAL OUTCOMES IN PATIENTS WITH AND WITHOUT METABOLIC SYNDROME FOLLOWING ACUTE CORONARY SYNDROME

Main Article Content

Dr. Anjali S. Patil, Dr. Aparna Patange, Dr. Dhairyashil Patil

Abstract

Introduction: Acute coronary syndrome (ACS) remains a leading cause of morbidity and mortality globally. Metabolic syndrome, characterized by a cluster of metabolic abnormalities, has emerged as a significant risk factor for cardiovascular diseases, including ACS.
Background Study: Hemolytic and megaloblastic anemia are kinds of anemia. Megaloblastic anemia is caused by vitamin B12 or folate deficits, while hemolytic anemia is caused by premature red blood cell destruction owing to autoimmune diseases or genetic abnormalities. Proper diagnosis and therapy are essential for treating these illnesses and improving patient outcomes.
Result: Our comparative analysis reveals significantly higher mortality rates, increased risk of recurrent cardiovascular events, and higher rates of hospital readmissions in patients with metabolic syndrome following ACS. Quality of life outcomes also indicate greater physical limitations and psychological distress in this patient population.
Conclusion: Metabolic syndrome significantly exacerbates adverse outcomes in patients post-ACS, emphasizing the critical need for early identification and tailored management strategies. Mechanistic insights underscore the importance of addressing metabolic abnormalities to optimize patient care and outcomes in this high-risk population.

Article Details

How to Cite
Dr. Dhairyashil Patil, D. A. S. P. D. A. P. (2024). A COMPARATIVE ANALYSIS OF CLINICAL OUTCOMES IN PATIENTS WITH AND WITHOUT METABOLIC SYNDROME FOLLOWING ACUTE CORONARY SYNDROME. Obstetrics and Gynaecology Forum, 34(3s), 496–503. Retrieved from https://obstetricsandgynaecologyforum.com/index.php/ogf/article/view/307
Section
Articles

Similar Articles

1 2 3 4 5 6 7 8 > >> 

You may also start an advanced similarity search for this article.